Helping Global Healthcare with New Technologies
Global healthcare spending is slowly increasing and is projected to reach trillions of dollars in a couple of years. Today, we see the growth of startups in the life sciences that seek to develop innovative drugs to treat common diseases. Many life sciences startups are beginning to appear on the scene but there are a few who are really making great waves in the industry.
Life sciences are being transformed by new technologies. These start companies are here to add value to these technologies. Some of the new technologies being used today are given below.
The blockchain technology aggregates data and is using automation to share these data. This technology makes the use of data easier and error-free.
Aritifial Intelligence or AI, is the intelligent use of data which is revolutionizing patient diagnosis and monitoring. With AI, treatment planning and drug discovery is made easier.
Now patients in rural care can have real-time care with virtual care. Doctors now use the internet to help patients receive care via computer. Now, doctors don’t have to make unnecessary visits to areas that are far from hospitals and doctors’ offices. Patients can get help for monitoring and to health coaches any time, any day.
The connection of medical devices to computer systems and software has changed the face of treatment. There isn ow better treatment and monitoring of patietns. Because of increased sensors, patient diagnosis is transformed when all devices are connected.
Below are some of the top life science startups we have today.
These startups have many great changes and have given a great impact on the biotechnology industry. The discovery of cutting-edge therpies like nanotechnology is helping healthcare improve in many aspects. All of these companies have current clinical trials. Drugs, vaccines, and treatment for cancer are beign developed. Each day the cause of healthcare is being advanced by continued new technologies.
Allogene Therapeutics, San Francisco, CA focuses on cancer-fighting immunotherapy using specially altered T-cells. Chimeric antigen receptors are produced when T-cells are taken from the patient’s blood to undergo modifications.
Fibrosis and immunology and immune-oncology and inflammation is the focus of Gossamer Bio, San Diego, CA.
The treatment for severe inflammation and autoimmune diseases is the focus of Viela Bio, Giathesburg, MD.
NanOlogy, Forth Worth, TX works on nanoparticles. The aim of these nanoparticle forms is for the delivery of therapeutics in cancer treatment.
The focus of Ambys Medicines, Redwood City, CA, is on the treatment of chronic liver disease. They are working on gene therapies, cell therapies, and drug therapies.
The focus of Cullinan Oncology, Cambridge is the development of drugs. Resources are shared in the company and each drug has its own chief executive overseeing development. If you are an exeucitve in the life sciences, visit this page.
The Bill and Melinda Gates Medical Research Institute, CAmbirdge focuses on vaccines. Their main project is the efficacy of the BCG vaccine for tuberculosis.